New RSV shot for babies shows strong protection in massive study
NCT ID NCT06325332
First seen Nov 06, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study looked at how well the medicine BEYFORTUS (nirsevimab) prevents serious RSV infections in babies. Nearly 50,000 infants were included, and researchers tracked doctor visits, hospital stays, and lab-confirmed RSV cases. The goal was to see if the shot reduces severe breathing problems and other complications from RSV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaiser Permanente Northern California: Site number 0001
Oakland, California, 94612, United States
Conditions
Explore the condition pages connected to this study.